Diabetes: New Diagnostic & Treatment Modalities

OR17-1

Metreleptin Treatment for Metabolic Abnormalities Associated with Lipodystrophy: Achieving A1C and Triglyceride Targets
Rebecca J. Brown, Karen Lutz, Elaine Cochran, Jim Pratt, Stephan Miller, Erich Blase, Matthew Wintle, Jean Lin Chan and Phillip Gorden

OR17-5

Diagnosis of Diabetes Mellitus by HbA1c ≥ 6.5% May Fail to Identify More Than Half of Diabetic Patients Defined by Fasting Plasma Glucose
Jinsun Choi, Jean Huang, Rudruidee Karnchanasorn, Horng-Yih Ou, Wei Feng, Lee-Ming Chuang, Ken C Chiu and Raynald Samoa